Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-06T15:44:02.384Z Has data issue: false hasContentIssue false

The Cal-DSH diversion guidelines

Published online by Cambridge University Press:  28 October 2020

Michael A. Cummings
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA
Charles Scott*
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento, California 95817, USA
Juan Carlos Arguello
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95816, USA
Ai-Li W. Arias
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA
Ashley M. Breth
Affiliation:
California Department of State Hospitals, Forensic Services Division, Sacramento, California 95816, USA
Darci Delgado
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA
Phil D. Harvey
Affiliation:
Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
Jonathan M. Meyer
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA
Jennifer O’Day
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Metropolitan, Norwalk, California 90650, USA
Megan Pollock
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA
George Proctor
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA
Tiffany Rector
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA
Benjamin Rose
Affiliation:
California Department of State Hospitals, DSH-Napa, Napa, California 94558, USA
Eric Schwartz
Affiliation:
California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Napa, Napa, California 94558, USA
Helga Thordarson
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA
Katherine Warburton
Affiliation:
California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95816, USA
Stephen M. Stahl
Affiliation:
California Department of State Hospitals, Psychopharmacology Services, Sacramento, California 95814, USA
*
*Author for correspondence: Charles Scott, MD Email: clscott@ucdavis.edu
Rights & Permissions [Opens in a new window]

Abstract

The Cal-DSH Diversion Guidelines provide 10 general guidelines that jurisdictions should consider when developing diversion programs for individuals with a serious mental illness (SMI) who become involved in the criminal justice system. Screening for SMI in a jail setting is reviewed. In addition, important treatment interventions for SMI and substance use disorders are highlighted with the need to address criminogenic risk factors highlighted.

Information

Type
Guidelines
Copyright
© The Author(s), 2020. Published by Cambridge University Press
Figure 0

Table 1. Central Eight Criminogenic Risk Factors10

Figure 1

Figure 1. The intercept model.

Figure 2

Table 2. Ten Key Aspects of Diversion Treatment

Figure 3

Figure 2. An integrated approach to substance abuse treatment.

Figure 4

Table 3. The Stepping Up Initiative Key Questions